Navigating the way to a positive HTA: avoiding snakes, climbing ladders

Health technology assessment (HTA) outcomes can make, or break, a product’s fate; depending on the HTA body’s remit, outcome decisions can affect a technology’s reimbursement status or position within a clinical pathway, and/or directly influence the price negotiation process. With such high stakes riding on HTA results, a timely, evidence-based and country-specific approach must be adopted. Read more from Hayward Medical Communications, an expert agency that partners with pharmaceutical, device and diagnostics companies to deliver effective market access strategies.